drugset / Trial / NCT01224015
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety and efficacy of botulinum toxin type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides) for patients who successfully completed Study 191622-099.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-10
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 24 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 44 iu | Other |
Indications
No indication recorded.